| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Chief Medical Officer | Apr 18, 2023 | Sale | $6.57 | 2,532 | 16,648 | 142,993 | Apr 19, 2023, 04:07 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Chief Medical Officer | Jan 10, 2023 | Sale | $5.24 | 7,825 | 41,003 | 143,208 | Jan 11, 2023, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Chief Medical Officer | Apr 19, 2022 | Sale | $35.37 | 4,062 | 143,673 | 151,033 | Apr 21, 2022, 04:04 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Senior VP Clinical Development | Jan 11, 2022 | Sale | $48.51 | 3,965 | 192,340 | 122,211 | Jan 13, 2022, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Senior VP Clinical Development | Dec 10, 2021 | Sale | $33.89 | 15,000 | 508,348 | 133,258 | Dec 13, 2021, 05:53 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Senior VP Clinical Development | Apr 16, 2021 | Sale | $83.30 | 3,275 | 272,809 | 67,200 | Apr 20, 2021, 04:00 PM |
Menu